A. Abdul-wahed, A. Gautier-stein, S. Casteras, M. Soty, D. Roussel et al.,

J. Tourette, N. Pleche, C. Zitoun, B. Gri, A. Sardella et al., A link between hepatic glucose production and peripheral energy metabolism via hepatokines, Mol Metab, vol.3, pp.531-543, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01350728

A. Abdul-wahed, S. Guilmeau, and C. Postic, Sweet Sixteenth for ChREBP: Established Roles and Future Goals, Cell Metab, vol.26, pp.324-341, 2017.

M. M. Adeva-andany, N. Pérez-felpete, C. Fernández-fernández, C. Donapetry-garcía, and C. Pazos-garcía, Liver glucose metabolism in humans, Biosci. Rep, vol.36, 2016.

L. Agius, Hormonal and Metabolite Regulation of Hepatic Glucokinase, Annu. Rev. Nutr, vol.36, pp.389-415, 2016.

L. Agius, Role of glycogen phosphorylase in liver glycogen metabolism, Molecular Aspects of Medicine, vol.46, pp.34-45, 2015.

C. Arden, J. L. Petrie, S. J. Tudhope, Z. Al-oanzi, A. J. Claydon et al., Elevated Glucose Represses Liver Glucokinase and Induces Its Regulatory Protein to Safeguard Hepatic Phosphate Homeostasis, Diabetes, vol.60, pp.3110-3120, 2011.

G. Baffy, E. M. Brunt, and S. H. Caldwell, Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace, Journal of Hepatology, vol.56, pp.1384-1391, 2012.

R. H. Bandsma, B. H. Prinsen, M. De-sain-van-der-velden, J. Rake, T. Boer et al., , 2008.

, Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a, Pediatr Res, vol.63, pp.702-707

R. H. Bandsma, G. P. Smit, and F. Kuipers, Disturbed lipid metabolism in glycogen storage disease type 1, Eur J Pediatr, vol.161, pp.65-69, 2014.

F. Benhamed, P. Denechaud, M. Lemoine, C. Robichon, M. Moldes et al.,

V. Ratziu, L. Serfaty, C. Housset, J. Capeau, J. Girard et al., The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Invest, vol.122, pp.2176-2194, 2012.

G. T. Berry, L. Baker, F. S. Kaplan, and C. L. Witzleben, Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome, Pediatr. Nephrol, vol.9, pp.287-291, 1995.

H. B. Bhatt and R. J. Smith, Fatty liver disease in diabetes mellitus, Hepatobiliary Surg Nutr, vol.4, pp.101-108, 2015.

N. Bruni, F. Rajas, S. Montano, F. Chevalier-porst, I. Maire et al., Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a, Ann. Hum. Genet, vol.63, pp.141-146, 1999.

R. Burcelin, M. Del-carmen-muñoz, M. T. Guillam, and B. Thorens, Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway, J. Biol. Chem, vol.275, pp.10930-10936, 2000.

C. Bertot, L. Adams, and L. A. , The Natural Course of Non-Alcoholic Fatty Liver Disease, 2016.

, Int J Mol Sci, vol.17

H. Chen, L. Wu, Y. Li, J. Meng, N. Lin et al., Advanced glycation end products increase carbohydrate responsive element binding protein expression and promote cancer cell proliferation, Mol. Cell. Endocrinol, vol.395, issue.23, pp.69-78, 2014.

L. Chen, D. J. Magliano, and P. Z. Zimmet, The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives, Nat Rev Endocrinol, vol.8, pp.228-236, 2012.

F. Chevalier-porst, D. Bozon, A. M. Bonardot, N. Bruni, G. Mithieux et al., Mutation analysis in 24 French patients with glycogen storage disease type 1a, J. Med. Genet, vol.33, pp.358-360, 1996.

M. Croset, F. Rajas, C. Zitoun, J. M. Hurot, S. Montano et al., Rat small intestine is an insulin-sensitive gluconeogenic organ, Diabetes, vol.50, pp.740-746, 2001.

R. Dentin, F. Benhamed, I. Hainault, V. Fauveau, F. Foufelle et al., Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice, Diabetes, vol.55, pp.2159-2170, 2006.

R. Dentin, L. Tomas-cobos, F. Foufelle, J. Leopold, J. Girard et al., Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver, J. Hepatol, vol.56, pp.199-209, 2012.

C. M. Donovan and A. G. Watts, Peripheral and central glucose sensing in hypoglycemic detection, Physiology (Bethesda), vol.29, pp.314-324, 2014.

B. Finan, C. Clemmensen, Z. Zhu, K. Stemmer, K. Gauthier et al.,

S. M. Hofmann, B. Yang, M. H. Tschöp, R. Dimarchi, and T. D. Müller, Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease, Cell, vol.167, pp.843-857, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01607311

B. Finan, B. Yang, N. Ottaway, D. L. Smiley, T. Ma et al., , p.24

K. M. Habegger, K. Fischer, J. E. Campbell, D. Sandoval, R. J. Seeley et al.,

W. Riboulet, J. Funk, C. Hertel, S. Belli, E. Sebokova et al., A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents, 2015.

. Med, , vol.21, pp.27-36

F. M. Fisher, M. Kim, L. Doridot, J. C. Cunniff, T. S. Parker et al., A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism, Mol Metab, vol.6, pp.14-21, 2017.

J. E. Gerich, C. Meyer, H. J. Woerle, and M. Stumvoll, Renal gluconeogenesis: its importance in human glucose homeostasis, Diabetes Care, vol.24, pp.382-391, 2001.

M. Gjorgjieva, J. Calderaro, L. Monteillet, M. Silva, M. Raffin et al., Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia, J. Hepatol, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02339527

M. Gjorgjieva, M. H. Oosterveer, G. Mithieux, and F. Rajas, Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment, Journal of Inborn Errors of Metabolism and Screening, vol.4, 2016.

M. Gjorgjieva, M. Raffin, A. Duchampt, A. Perry, A. Stefanutti et al., Progressive development of renal cysts in glycogen storage disease type I, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02339729

. Mol and . Genet, , vol.25, pp.3784-3797

A. Grefhorst, M. Schreurs, M. H. Oosterveer, V. A. Cortés, R. Havinga et al., Carbohydrate-response-element-binding protein (ChREBP), vol.432, pp.249-254, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00535587

M. T. Guillam, R. Burcelin, and B. Thorens, Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.12317-12321, 1998.

R. A. Haeusler, S. Camastra, B. Astiarraga, M. Nannipieri, M. Anselmino et al., Decreased expression of hepatic glucokinase in type 2 diabetes, Mol Metab, vol.4, pp.222-226, 2015.

J. M. Hazlehurst, C. Woods, T. Marjot, J. F. Cobbold, and J. W. Tomlinson, Non-alcoholic fatty liver disease and diabetes, Metabolism, vol.65, pp.1096-1108, 2016.

J. Hicks, E. Wartchow, and G. Mierau, Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment, Ultrastruct Pathol, vol.35, pp.183-196, 2011.

B. S. Hijmans, A. Boss, T. H. Van-dijk, M. Soty, H. Wolters et al., Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia, Hepatology, vol.66, pp.2042-2054, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02339628

K. Iizuka, B. Miller, and K. Uyeda, Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice, 2006.

, Am. J. Physiol. Endocrinol. Metab, vol.291, pp.358-364

G. Jiang and B. B. Zhang, Glucagon and regulation of glucose metabolism, American Journal of Physiology -Endocrinology and Metabolism, vol.284, pp.671-678, 2003.

E. S. Jin, M. H. Lee, R. E. Murphy, and C. R. Malloy, Pentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver, American Journal of Physiology-Endocrinology and Metabolism, vol.314, pp.543-551, 2018.

K. Kaneko, M. Soty, C. Zitoun, A. Duchampt, M. Silva et al., The role of kidney in the inter-organ coordination of endogenous glucose 26 production during fasting, 2018.

M. Kim, S. A. Krawczyk, L. Doridot, A. J. Fowler, J. X. Wang et al., ChREBP regulates fructoseinduced glucose production independently of insulin signaling, Journal of Clinical Investigation, vol.126, pp.4372-4386, 2016.

S. Y. Kim, D. A. Weinstein, M. F. Starost, B. C. Mansfield, and J. Y. Chou, Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia, J. Hepatol, vol.48, pp.479-485, 2008.

P. S. Kishnani, S. L. Austin, J. E. Abdenur, P. Arn, D. S. Bali et al., Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of, American College of Medical Genetics and Genomics, vol.16, p.1, 2014.

H. Koga, S. Kaushik, and A. M. Cuervo, Altered lipid content inhibits autophagic vesicular fusion, FASEB J, vol.24, pp.3052-3065, 2010.

H. Y. Lan, Diverse Roles of TGF-?/Smads in Renal Fibrosis and Inflammation, Int J Biol Sci, vol.7, pp.1056-1067, 2011.

D. Lewis and C. Wanner, Diabetes: Should we use fibrates in patients with diabetes and mild CKD?, Nature Reviews Nephrology, vol.8, pp.201-202, 2012.

H. V. Lin and D. Accili, Hormonal regulation of hepatic glucose production in health and disease, Cell Metab, vol.14, pp.9-19, 2011.

Y. Mao, F. Yu, J. Wang, C. Guo, and X. Fan, Autophagy: a new target for nonalcoholic fatty liver disease therapy, Hepat Med, vol.8, pp.27-37, 2016.

D. H. Martens, J. P. Rake, G. Navis, V. Fidler, C. M. Van-dael et al., , p.27, 2009.

, in Glycogen Storage Disease Type I, Natural Course, and Renopreservative Effects of ACE Inhibition, Clin J Am Soc Nephrol, vol.4, pp.1741-1746

X. Meng, P. M. Tang, .. Li, J. Lan, and H. Y. , TGF-?/Smad signaling in renal fibrosis, Front Physiol, vol.6, 2015.

L. Monteillet, M. Gjorgjieva, M. Silva, V. Verzieux, L. Imikirene et al., Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02339561

,

H. R. Mundy and P. J. Lee, Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction?, Med. Hypotheses, vol.59, pp.110-114, 2002.

G. Musso, M. Cassader, and R. Gambino, Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies, Nat Rev Drug Discov, vol.15, pp.249-274, 2016.

E. Mutel, A. Gautier-stein, A. Abdul-wahed, M. Amigó-correig, C. Zitoun et al., Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice, Diabetes, vol.60, pp.3121-3131, 2011.

M. H. Oosterveer, C. Mataki, H. Yamamoto, T. Harach, N. Moullan et al., LRH-1-dependent glucose sensing determines intermediary metabolism in liver, J. Clin. Invest, vol.122, pp.2817-2826, 2012.

O. E. Owen, P. Felig, A. P. Morgan, J. Wahren, and G. F. Cahill, Liver and kidney metabolism during prolonged starvation, J. Clin. Invest, vol.48, pp.574-583, 1969.

V. Patney, K. Chaudhary, and A. Whaley-connell, Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition, Adv Chronic Kidney Dis, vol.25, pp.158-165, 2018.

A. Penhoat, L. Fayard, A. Stefanutti, G. Mithieux, and F. Rajas, , 2014.

, Metab. Clin. Exp, vol.63, pp.104-111

R. J. Perry, D. Zhang, X. Zhang, J. L. Boyer, and G. I. Shulman, Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats, Science, vol.347, pp.1253-1256, 2015.

B. Pillot, M. Soty, A. Gautier-stein, C. Zitoun, and G. Mithieux, Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin, Endocrinology, vol.150, pp.616-624, 2009.

C. Postic and J. Girard, Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, J. Clin. Invest, vol.118, pp.829-838, 2008.

N. Poungvarin, B. Chang, M. Imamura, J. Chen, K. Moolsuwan et al., , 2015.

. Genome-wide, Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin, Endocrinology, vol.156, pp.1982-1994

A. Raimondo, M. G. Rees, and A. L. Gloyn, Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism, Curr. Opin. Lipidol, vol.26, pp.88-95, 2015.

F. Rajas, H. Jourdan-pineau, A. Stefanutti, E. A. Mrad, P. B. Iynedjian et al., , 2007.

F. Rajas, P. Labrune, and G. Mithieux, Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders, Diabetes Metab, vol.39, pp.377-387, 2013.

P. J. Roach, A. A. Depaoli-roach, T. D. Hurley, and V. S. Tagliabracci, Glycogen and its metabolism: some new developments and old themes, Biochem. J, vol.441, pp.763-787, 2012.

M. Soty, A. Gautier-stein, F. Rajas, and G. Mithieux, Gut-Brain Glucose Signaling in Energy Homeostasis, Cell Metabolism, vol.25, pp.1231-1242, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02339600

J. H. Stoot, R. J. Coelen, M. C. De-jong, and C. H. Dejong, Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases, HPB (Oxford), vol.12, pp.509-522, 2010.

B. Thorens, GLUT2, glucose sensing and glucose homeostasis, Diabetologia, vol.58, pp.221-232, 2015.

B. Thorens, Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes, Am. J. Physiol, vol.270, pp.541-553, 1996.

R. Ting, A. C. Keech, P. L. Drury, M. W. Donoghoe, J. Hedley et al., FIELD Study Investigators, 2012. Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study, Diabetes Care, vol.35, pp.218-225

X. Tong, F. Zhao, A. Mancuso, J. J. Gruber, and C. B. Thompson, The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.21660-21665, 2009.

V. Vallon and R. Komers, Pathophysiology of the diabetic kidney, Compr Physiol, vol.1, pp.1175-1232, 2011.

E. Van-schaftingen, M. Detheux, and M. Veiga-da-cunha, Short-term control of glucokinase activity: role of a regulatory protein, FASEB J, vol.8, pp.414-419, 1994.

L. R. Waskowicz, J. Zhou, D. J. Landau, E. D. Brooks, A. Lim et al.,

Y. Wu, S. Grant, S. P. Young, B. B. Huat, P. M. Yen et al., Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia, Hum. Mol. Genet, 2018.

H. Watanabe, Y. Inaba, K. Kimura, M. Matsumoto, S. Kaneko et al., , p.2, 2018.

D. A. Weinstein, U. Steuerwald, C. F. De-souza, and T. G. Derks, Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and, 2018.

, Pediatr. Clin. North Am, vol.65, pp.247-265

R. M. Williamson, J. F. Price, S. Glancy, E. Perry, L. D. Nee et al., Edinburgh Type 2 Diabetes Study Investigators, 2011. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetes Care, vol.34, pp.1139-1144

L. Yang, P. Li, S. Fu, E. S. Calay, and G. S. Hotamisligil, Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance, Cell Metab, vol.11, pp.467-478, 2010.

W. H. Yiu, C. Pan, R. A. Ruef, W. Peng, M. F. Starost et al., The angiotensin system mediates renal fibrosis in glycogen storage disease type Ia nephropathy, Kidney Int, vol.73, pp.716-723, 2008.